Skip to main content
Premium Trial:

Request an Annual Quote

Test for Them All

New tests can detect SARS-CoV-2 as well as other viruses like influenza and respiratory syncytial virus, the New York Times reports. It adds that such tests could be helpful come the next flu season.

This past flu season was mild, the Times notes, but as more children may then be back at in-person school and as mask-wearing may decline, the flu may be more prevalent next season. University of Washington's Geoffrey Baird tells it that people will then want to know whether they have the flu or SARS-CoV-2.

One PCR-based test from Cepheid detects two influenza viruses and RSV as well as SARS-CoV-2, while Roche has a test that detects influenza A and B in addition to SARS-CoV-2 and a test from bioMérieux detects more than 20 viruses and bacteria, the Times reports, noting that some labs have further developed their own in-house multiplex tests.

One question facing test-makers is just how many viruses and bacteria to include on their panels, the Times adds. It also notes that most people used to not be interested in knowing exactly which pathogen was causing their respiratory symptoms, but as Alexandra Valsamakis from Roche Diagnostics Solutions tells it, COVID-19 has changed that.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.